Starting on:
Jan 11, 2021
Ending on:
Dec 31, 2021
Moderator(s):
Venue:
Virtual- ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Jan 11, 2021
Ending on:
Dec 31, 2021
Moderator(s):
Virtual- ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
CBP 103: INTERNATIONAL CANCER INSTITUTE BREAST CANCER PRECEPTORSHIP
Starting on:
Jan 11, 2021 8:00 AM
Jan 11, 2021 8:00 AM
Ending on:
Dec 31, 2021 5:00 PM
Dec 31, 2021 5:00 PM
Venue:
Virtual- ICI
Virtual- ICI
Description
Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Breast Cancer patients in sub-Saharan Africa incorporating Biosimilars.
Objectives
At the end of this educational activity, participants should be able to:
1. Understand the Epidemiology of Breast cancer in sub-Saharan Africa (SSA)
2. discuss breast cancer screening, risk factors and protective factors associated with breast cancer
3. recognize the role of pathological diagnosis, staging, molecular subtypes, the prognostic and therapeutic significance of tumor estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression for breast cancer
4. Interpret mammograms and appreciate the role of radiology in breast cancer management
5. To review the optimal treatment strategies for Breast cancer: chemotherapy, hormonal, targeted agents, monoclonal antibodies etc. Includes Standard of care Treatment protocols
6. describe the current trends in the locoregional and systemic management of operable early-stage breast cancer
7. To understand the role of multidisciplinary team in Breast cancer management
8. To understand the role of Surgery in the management of Breast cancer
9. To understand the role of radiotherapy in the management of breast cancer
10. To recall the current goals and standard of care in management of metastatic breast cancer.
11. To understand the role of Palliative, supportive and survivorship care in Breast cancer management
12. To discuss the role and integration of Biosimilars in breast cancer management
13. Appreciate the research priority areas in breast cancer in SSA
Presenters
-
Dr.
Adem Yesufe
Clinical Oncologist
St. Paul's Hospital, Millenium Medical College in Addis Ababa, Ethiopia -
Dr.
Helena Musau
Clinical Oncologist
Kenyatta University Teaching and Referral Hospital -
Prof.
Emmanuel Rudakemwa
Associate Clinical professor, Imaging and Radiation
King Faisal Hospital, Rwanda -
Dr.
Irene Weru
Oncology Pharmacist
Kenyatta National Hospital -
Dr.
Bahaty Riogi
Consultant Breast Surgeon
Kisii Teaching and Referral Hospital -
Dr.
Verna Vanderpuye
Consultant Radiation Oncologist
National Center for Radiotherapy Oncology- Accra, Ghana -
Dr.
Njoki Njiraini
Clinical Oncologist
Kenyatta University Teaching and Referral Hospital -
Dr.
Sitna Mwanzi
Consultant Physician & Medical Oncologist
Aga Khan University Hospital -
Prof.
Chite Asirwa
Consultant Physician, Medical Oncologist & Hematologist
International Cancer Institute -
Dr.
Zipporah Ali
Palliative Care Specialist
KEHPCA -
Dr.
David Wata
Oncology Pharmacist
Kenyatta National Hospital